What should I do if my GLP-1 provider receives an FDA warning?

Review the specific alert details, contact your provider for their response, and consult your primary care doctor if you have safety concerns about your medication.

Are compounded GLP-1 medications safe?

Compounded medications are not FDA-approved but are legal when prepared by licensed pharmacies. The FDA has issued warnings about some compounders. Check our safety alerts for the latest enforcement actions.

GLP-1 Safety Alerts & FDA Updates

Q: How does GLP1 Clinics track FDA alerts?

We run an automated scan of FDA primary sources — the FDA press release and drug RSS feeds, the openFDA enforcement API, and FDA's warning letter listing — for actions related to GLP-1 medications and weight loss providers. Every candidate links to its FDA source and is reviewed by a person before it is published, so this page shows reviewed items rather than raw scanner output.

We track FDA warning letters, safety updates, enforcement actions and recalls related to GLP-1 medications and weight loss providers. Every alert below links to the FDA source and is reviewed before it appears here.

2 reviewed alerts · most recent FDA action dated 19 March 2026

This list may not be current. The most recent reviewed FDA action here is 159 days old (threshold 45 days). Check FDA recalls and safety alerts directly for anything newer.

Pharmacist examining GLP-1 medication vial for safety verification

InfoSafety UpdateMarch 19, 2026

FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide

The FDA approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection for weight loss and long-term maintenance of weight loss in certain adult patients. This approval marks the fourth product approved under the Commissioner's National Priority Voucher pilot program.

View FDA Source

WarningWarning LetterMarch 3, 2026

FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s

The FDA issued 30 warning letters to telehealth companies for making false or misleading claims regarding compounded GLP-1 products offered on their websites. This enforcement action targets illegal marketing practices by telehealth providers offering weight loss services.

View FDA Source

What to Do If Your Provider Is Flagged

Don't panic

An FDA alert does not always mean your medication is unsafe. Many alerts are administrative or related to labeling and marketing practices, not product safety.

Check the specific alert details

Read the full FDA notice linked in the alert. Understand whether the issue affects the medication you are taking or only certain product batches or business practices.

Contact your provider directly

Ask your provider about the alert and what steps they are taking in response. A reputable provider will be transparent about any FDA communications.

If concerned, consult your primary care doctor

Your primary care physician can help you evaluate whether to continue, pause, or switch your GLP-1 treatment based on the specific alert and your health history.

Report issues to FDA MedWatch

If you experience adverse effects or suspect a safety issue, report it directly to the FDA through their MedWatch program at fda.gov/medwatch.

Find a Verified Provider

Search our directory of 9,700+ verified GLP-1 clinics to find a provider you can trust.

Find a Provider About Our Methodology

Find a GLP-1 provider that takes safety seriously

Every clinic in our directory passes federal-database verification, BBB accreditation checks, and active-website confirmation. Match with one in 90 seconds.

Take the 90-second quiz